Nationwide seroprevalence of SARS-CoV-2 IgG antibodies among four groups of primary health-care workers and their household contacts 6 months after the initiation of the COVID-19 vaccination campaign in france: seroPRIM study protocol - Archive ouverte HAL Access content directly
Journal Articles Pathogens Year : 2021

Nationwide seroprevalence of SARS-CoV-2 IgG antibodies among four groups of primary health-care workers and their household contacts 6 months after the initiation of the COVID-19 vaccination campaign in france: seroPRIM study protocol

Pascaline Rabiega
  • Function : Author
Julien Laupie
  • Function : Author
Nathalie Abraham
  • Function : Author

Abstract

Background: The protocol study will focus on the seroprevalence of IgG antibodies to SARS-CoV-2 achieved by vaccination and/or natural protection as well as the history, symptoms, and risk factors for SARS-CoV-2 in four primary health-care workers (PHCWs) and their household contacts in metropolitan France. Methods: Here, we propose a protocol for a nationwide survey to determine the seroprevalence of IgG antibodies to SARS-CoV-2 achieved by vaccination and/or natural protection in four PHCW populations (general practitioners, pediatricians, pharmacists and assistants, and dentists and assistants) and their household contacts. Participants will be included from June to July 2021 (Phase 1) among PHCW populations located throughout metropolitan France. They will be asked to provide a range of demographic and behavioral information since the first SARS-CoV-2 wave and a self-sampled dried blood spot. Phase 1 will involve also a questionnaire and serological study of PHCWs’ household contacts. Seroprevalence will be estimated using two ELISAs designed to detect specific IgG antibodies to SARS-CoV-2 in humoral fluid, and these results will be confirmed using a virus neutralization test. This study will be repeated from November to December 2021 (Phase 2) to evaluate the evolution of immune status achieved by vaccination and/or natural protection of PHCWs and to describe the history of exposure to SARS-CoV-2.
Fichier principal
Vignette du fichier
pathogens-10-00911.pdf (467.04 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03329884 , version 1 (07-10-2021)

Licence

Attribution

Identifiers

Cite

Marie Pouquet, Dorine Decarreaux, Pol Prévot-Monsacré, Corentin Hervé, Andréas Werner, et al.. Nationwide seroprevalence of SARS-CoV-2 IgG antibodies among four groups of primary health-care workers and their household contacts 6 months after the initiation of the COVID-19 vaccination campaign in france: seroPRIM study protocol. Pathogens, 2021, 10 (7), pp.911. ⟨10.3390/pathogens10070911⟩. ⟨hal-03329884⟩
120 View
58 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More